August 27, 2024Open Access

Hepatitis C treatment outcome among people in prison: The SToP‐C study

Key Points

Key points are not available for this paper at this time.

Abstract

Hepatitis C virus (HCV) burden is higher among people in prison given high prevalence of injecting drug use. This study evaluated direct-acting antiviral (DAA) treatment outcome in prisons.

Read Full Paperexternally

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Ryan et al. (Tue,) studied this question.

synapsesocial.com/papers/68e5ab8eb6db64358754559e https://doi.org/https://doi.org/10.1111/liv.16074

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1An Algorithm for the Grading of Activity in Chronic Hepatitis C1996 · 4,023 citations
2Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review2023 · 263 citations
3Supported housing for prisoners returning to the community: A review of the literature2018 · 16 citations
4The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study2019 · 247 citations
5Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study2022 · 653 citations